세계의 인공 장기 및 바이오닉스 시장 : 부문별 예측(2025-2030년)

The Artificial Organ & Bionics Market was valued at USD 23.34 billion in 2023, expected to reach USD 25.45 billion in 2024, and is projected to grow at a CAGR of 9.10%, to USD 42.97 billion by 2030.

The artificial organ and bionics market involves the development of biocompatible devices that enhance or substitute the function of impaired organs or tissues. Defined by its integration of biotechnology and bioengineering, the scope encompasses artificial kidneys, hearts, lungs, ears, and more. This field is necessitated by the rising prevalence of organ failures, chronic diseases, and the shortage of donor organs. Applications span numerous medical fields, prominently in cardiac and diabetes management (e.g., bionic pancreas), mobility enhancement (prosthetics), and sensory restoration (cochlear implants). End-users predominantly include hospitals, research institutions, and patients requiring rehabilitation or quality of life improvements.

Market growth is primarily driven by technological advancements, such as 3D printing and stem cell technology, which are revolutionizing device manufacturing and personalized medicine. Favorable regulatory policies and increased healthcare expenditure further catalyze market expansion. Opportunities abound in markets with aging populations and increasing incidence of organ failure. Emerging regions, technologically advanced product offerings, and collaborations for innovative solutions are potential levers for growth. Businesses should pivot towards these opportunities by investing in R&D, forming strategic alliances, and emphasizing personalized medicine for market penetration.

However, the market faces constraints, including high costs of development and implementation, stringent regulatory compliance, and ethical concerns regarding long-term integration and functionality. Additionally, technological complexity and required multidisciplinary expertise pose challenges for swift market adoption.

To innovate, focus should be on enhancing biocompatibility and longevity of devices, reducing manufacturing costs, and leveraging AI for predictive analytics in patient-specific solutions. Exploring minimally invasive installation methods and integrating IoT for monitoring could also provide a competitive edge. The market is dynamic and burgeoning, yet intensely requires balancing cost, accessibility, and technological innovation. A strategic approach focusing on overcoming existing limitations while capitalizing on new opportunities will be critical for success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Organ & Bionics Market

The Artificial Organ & Bionics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of organ failure due to chronic diseases
  • Increasing cases of road accidents leading to amputations
  • Modernization of healthcare infrastructure and rise in healthcare spending
• Market Restraints
  • High costs associated with artificial implantation procedures
• Market Opportunities
  • Advancement in the implantation of artificial organ procedures
  • Development of new and improved artificial organs
• Market Challenges
  • Availability of stringent regulatory frameworks

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Organ & Bionics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Organ & Bionics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Organ & Bionics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Organ & Bionics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Organ & Bionics Market

A detailed market share analysis in the Artificial Organ & Bionics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Organ & Bionics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Organ & Bionics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Organ & Bionics Market

A strategic analysis of the Artificial Organ & Bionics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Organ & Bionics Market, highlighting leading vendors and their innovative profiles. These include Alt-Bionics, LLC, Axiles Bionics, Baxter International Inc., Berlin Heart GmbH, Beta Bionics, Inc., Bionic India, Boston Scientific Corporation, Carmat SA, COVVI Ltd., Ekso Bionics Holdings, Inc., German Bionic Systems GmbH, iWALKFree, Inc., Jarvik Heart, Inc., Medtronic Plc, Nipro Corporation, Open Bionics Ltd., Pixium Vision SA, ReWalk Robotics Ltd., Sonova AG, SynCardia Systems, LLC, Vivani Medical, Inc., Zimmer Biomet Holdings, Inc., and Ossur hf..

Market Segmentation & Coverage

This research report categorizes the Artificial Organ & Bionics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Artificial Bionics and Artificial Organ. The Artificial Bionics is further studied across Bionic Limbs, Brain Bionics, Cochlear Implants, Exoskeleton, and Vision Bionics. The Artificial Organ is further studied across Heart, Kidney, Liver, Lungs, and Pancreas.
• Based on Technology, market is studied across Electronic and Mechanical.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of organ failure due to chronic diseases
    • 5.1.1.2. Increasing cases of road accidents leading to amputations
    • 5.1.1.3. Modernization of healthcare infrastructure and rise in healthcare spending
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with artificial implantation procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement in the implantation of artificial organ procedures
    • 5.1.3.2. Development of new and improved artificial organs
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of stringent regulatory frameworks
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Organ & Bionics Market, by Product

• 6.1. Introduction
• 6.2. Artificial Bionics
  • 6.2.1. Bionic Limbs
  • 6.2.2. Brain Bionics
  • 6.2.3. Cochlear Implants
  • 6.2.4. Exoskeleton
  • 6.2.5. Vision Bionics
• 6.3. Artificial Organ
  • 6.3.1. Heart
  • 6.3.2. Kidney
  • 6.3.3. Liver
  • 6.3.4. Lungs
  • 6.3.5. Pancreas

7. Artificial Organ & Bionics Market, by Technology

• 7.1. Introduction
• 7.2. Electronic
• 7.3. Mechanical

8. Americas Artificial Organ & Bionics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Artificial Organ & Bionics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Artificial Organ & Bionics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alt-Bionics, LLC
• 2. Axiles Bionics
• 3. Baxter International Inc.
• 4. Berlin Heart GmbH
• 5. Beta Bionics, Inc.
• 6. Bionic India
• 7. Boston Scientific Corporation
• 8. Carmat SA
• 9. COVVI Ltd.
• 10. Ekso Bionics Holdings, Inc.
• 11. German Bionic Systems GmbH
• 12. iWALKFree, Inc.
• 13. Jarvik Heart, Inc.
• 14. Medtronic Plc
• 15. Nipro Corporation
• 16. Open Bionics Ltd.
• 17. Pixium Vision SA
• 18. ReWalk Robotics Ltd.
• 19. Sonova AG
• 20. SynCardia Systems, LLC
• 21. Vivani Medical, Inc.
• 22. Zimmer Biomet Holdings, Inc.
• 23. Ossur hf.